Literature DB >> 11329573

Acute chest syndrome after abdominal surgery in children with sickle cell disease: Is a laparoscopic approach better?

P W Wales1, E Carver, M W Crawford, P C Kim.   

Abstract

BACKGROUND/
PURPOSE: Acute chest syndrome (ACS) is the leading cause of hospitalization and death among patients with sickle cell disease (SCD). Surgery is a risk factor for the development of ACS. It has been suggested that laparoscopic surgery could diminish the risk of sickle-related complications; therefore, more procedures may be encouraged in asymptomatic patients. The goal of the authors was to determine the incidence of postoperative ACS and assess for predisposing factors in all sickle cell patients undergoing abdominal surgery.
METHODS: A retrospective analysis of all sickle cell patients receiving abdominal surgery (open and laparoscopic) between 1994 and 1998 was conducted. Data pertaining to demographics, perioperative clinical status, postoperative care, and outcome were collected and analyzed using Student's t test or chi(2) where appropriate.
RESULTS: Fifty-four children underwent 62 procedures (35 abdominal and 27 extracavitary). All abdominal cases were either cholecystectomy or splenectomy (22 laparoscopic and 13 open). ACS occurred in 7 of 62 (11.3%) overall, and all were in abdominal cases 7 of 35 (20%). ACS occurred in 5 of 22 (22.7%) laparoscopic cases and 2 of 13 (15.4%) open cases. Operating time was significantly longer in the laparoscopic group compared with open cases (P <.05). A higher percentage of patients who had ACS had at least 1 previous episode (71.4% v 39.3%; P value not significant) and a smaller percentage of ACS patients received a preoperative blood transfusion (14.3% v 32.1%; P value not significant). Postoperative hospitalization was prolonged if ACS occurred (9 +/- 2 v 3 +/- 2 days; P <.05).
CONCLUSIONS: Abdominal surgery carries a significantly high risk (20%) of ACS. Laparoscopy does not decrease the incidence of ACS compared with open approach. Predisposing factors were not significant in predicting postoperative ACS. There is considerable morbidity and potential cost implications in patients with ACS. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2001        PMID: 11329573     DOI: 10.1053/jpsu.2001.22944

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

Review 1.  Antibiotics for treating acute chest syndrome in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno; Jennifer M Knight-Madden
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06

2.  Low-impact laparoscopic cholecystectomy is associated with decreased postoperative morbidity in patients with sickle cell disease.

Authors:  Nicola de'Angelis; Solafah Abdalla; Maria Clotilde Carra; Vincenzo Lizzi; Aleix Martínez-Pérez; Anoosha Habibi; Pablo Bartolucci; Frédéric Galactéros; Alexis Laurent; Francesco Brunetti
Journal:  Surg Endosc       Date:  2017-11-02       Impact factor: 4.584

3.  Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry.

Authors:  Sofia Mouttalib; Henry E Rice; Denise Snyder; Justin S Levens; Audra Reiter; Pauline Soler; Jennifer A Rothman; Courtney D Thornburg
Journal:  Pediatr Blood Cancer       Date:  2012-01-11       Impact factor: 3.167

4.  Informed consent and choice in cholecystectomy.

Authors:  Mark D Stringer
Journal:  Pediatr Surg Int       Date:  2004-10       Impact factor: 1.827

5.  Predictors of Recurrent Acute Chest Syndrome in Pediatric Sickle Cell Disease: A Retrospective Case-Control Study.

Authors:  Abdullah A Yousef; Hwazen A Shash; Ali N Almajid; Ammar A Binammar; Hamza Ali Almusabeh; Hassan M Alshaqaq; Mohammad H Al-Qahtani; Waleed H Albuali
Journal:  Children (Basel)       Date:  2022-06-15

6.  Antibiotics for treating acute chest syndrome in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno; Jennifer M Knight-Madden
Journal:  Cochrane Database Syst Rev       Date:  2019-09-18

7.  Splenectomy in Patients with Sickle Cell Disease in Tabuk.

Authors:  Asmaa Ghmaird; Mohammad Mohammad Alnoaiji; Sawsan Al-Blewi; Shaimaa Zaki; Ahmad El-Lewi; Nehal Ahmad
Journal:  Open Access Maced J Med Sci       Date:  2016-02-29

8.  Risks and Benefits of Prophylactic Transfusion before Cholecystectomy in Sickle Cell Disease.

Authors:  Elise Rambaud; Brigitte Ranque; Sofia Tsiakyroudi; Laure Joseph; Nathalie Bouly; Richard Douard; Anne François; Jacques Pouchot; Jean-Benoît Arlet
Journal:  J Clin Med       Date:  2022-07-09       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.